Literature DB >> 16849433

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

Claus Cursiefen1, Lu Chen, Magali Saint-Geniez, Pedram Hamrah, Yiping Jin, Saadia Rashid, Bronislaw Pytowski, Kris Persaud, Yan Wu, J Wayne Streilein, Reza Dana.   

Abstract

Transparency of the cornea, the window of the eye, is a prerequisite for vision. Angiogenesis into the normally avascular cornea is incompatible with good vision and, therefore, the cornea is one of the few tissues in the human body where avascularity is actively maintained. Here, we provide evidence for a critical mechanism contributing to corneal avascularity. VEGF receptor 3, normally present on lymphatic and proliferating blood vascular endothelium, is strongly constitutively expressed by corneal epithelium and is mechanistically responsible for suppressing inflammatory corneal angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849433      PMCID: PMC1544098          DOI: 10.1073/pnas.0506112103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.

Authors:  J Hori; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

Review 2.  Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology.

Authors:  Claus Cursiefen; Lu Chen; M Reza Dana; J Wayne Streilein
Journal:  Cornea       Date:  2003-04       Impact factor: 2.651

3.  Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.

Authors:  C M Lai; M Brankov; T Zaknich; Y K Lai; W Y Shen; I J Constable; I Kovesdi; P E Rakoczy
Journal:  Hum Gene Ther       Date:  2001-07-01       Impact factor: 5.695

4.  Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.

Authors:  H Kubo; T Fujiwara; L Jussila; H Hashi; M Ogawa; K Shimizu; M Awane; Y Sakai; A Takabayashi; K Alitalo; Y Yamaoka; S I Nishikawa
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

5.  Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo.

Authors:  Nirbhai Singh; Shivan Amin; Elizabeth Richter; Saadia Rashid; Vincent Scoglietti; Pooja D Jani; Jin Wang; Rajwinder Kaur; Jayakrishna Ambati; Zheng Dong; Balamurali K Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-05       Impact factor: 4.799

6.  VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.

Authors:  Tuomas T Rissanen; Johanna E Markkanen; Marcin Gruchala; Tommi Heikura; Antti Puranen; Mikko I Kettunen; Ivana Kholová; Risto A Kauppinen; Marc G Achen; Steven A Stacker; Kari Alitalo; Seppo Ylä-Herttuala
Journal:  Circ Res       Date:  2003-04-24       Impact factor: 17.367

7.  Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Authors:  Hajime Kubo; Renhai Cao; Ebba Brakenhielm; Taija Mäkinen; Yihai Cao; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

8.  Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.

Authors:  Claus Cursiefen; Ursula Schlötzer-Schrehardt; Michael Küchle; Lydia Sorokin; Silvana Breiteneder-Geleff; Kari Alitalo; David Jackson
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

Review 9.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

Review 10.  Lymphangiogenesis and cancer metastasis.

Authors:  Steven A Stacker; Marc G Achen; Lotta Jussila; Megan E Baldwin; Kari Alitalo
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  104 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.

Authors:  Jeremy M Sivak; Allison C Ostriker; Amber Woolfenden; John Demirs; Rosemarie Cepeda; Debby Long; Karen Anderson; Bruce Jaffee
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

Review 3.  Emerging techniques to treat corneal neovascularisation.

Authors:  J Menzel-Severing
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

4.  Corneal epithelial MT1-MMP inhibits vascular endothelial cell proliferation and migration.

Authors:  Dimitri T Azar; Fabio H Casanova; Tatsuya Mimura; Sandeep Jain; Zhongjun Zhou; Kyu Yeon Han; Jin-Hong Chang
Journal:  Cornea       Date:  2010-03       Impact factor: 2.651

5.  Curcumin nanoparticles inhibit corneal neovascularization.

Authors:  Nirparaj Pradhan; Rajdeep Guha; Sushovan Chowdhury; Sudip Nandi; Aditya Konar; Sarbani Hazra
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

6.  Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.

Authors:  Amir R Hajrasouliha; Toshinari Funaki; Zahra Sadrai; Takaaki Hattori; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

Review 7.  Graft failure IV. Immunologic mechanisms of corneal transplant rejection.

Authors:  Eva-Marie Chong; M Reza Dana
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

8.  Gene Expression Profile of Vascular Endothelial Growth Factors (VEGFs) and Platelet-derived Growth Factors (PDGFs) in the Normal Cornea.

Authors:  Andrei Radu Dan Cosnita; Marius Raica; Mihai Poenaru Sava; Anca Maria Cimpean
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 9.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

10.  Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.

Authors:  Alexander J Leedom; Aaron B Sullivan; Baiyan Dong; Denise Lau; Karsten Gronert
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.